Rogers Corporation Press Releases

Uncovering cancer in today's anatomic pathology lab
06/04/2013 1:00PM - PR Newswire

Ventana and Barco revolutionize digital pathology viewing experience
06/03/2013 1:00PM - PR Newswire

Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate (ADC) Collaborator Data at ASCO Annual Meeting
06/02/2013 9:00AM - Business Wire

Genentech’s Medicine Avastin Plus Chemotherapy Improved Survival in Women with Advanced Cervical Cancer, Compared to Chemotherapy Alone
06/02/2013 7:30AM - Business Wire

Genentech Announces Final Phase III Study Results of Avastin Plus Radiotherapy and Chemotherapy in People with an Aggressive Form of Brain Cancer
06/01/2013 4:30PM - Business Wire

Rogers Corporation to Present D.A. Davidson & Co. 5th Annual Technology Forum
05/22/2013 10:00AM - Business Wire

Genentech’s Obinutuzumab (GA101) Significantly Reduced the Risk of Disease Progression or Death in People with One of the Most Common Forms of Blood Cancer
05/15/2013 6:00PM - Business Wire

Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO
05/15/2013 1:00AM - Business Wire

FDA Approves Tarceva (Erlotinib) Tablets and Cobas EGFR Mutation Test for Specific Type of Lung Cancer
05/14/2013 7:14PM - Business Wire

Rogers Corporation Updates on Cost Improvement Initiatives
05/14/2013 5:00PM - Business Wire

Rogers Corporation Reports 2013 First Quarter Results
04/30/2013 4:01PM - Business Wire

FDA Approves ACTEMRA® for Children Living with a Rare Form of Arthritis
04/30/2013 11:30AM - Business Wire

Rogers Corporation to Present at Jefferies 2013 Global Technology, Media and Telecom Conference
04/30/2013 10:59AM - Business Wire

Rogers Corporation Invites You to Join its 2013 First Quarter Earnings Conference Call
04/23/2013 11:00AM - Business Wire

Rogers Corporation Updates Guidance for the First Quarter
04/18/2013 7:47AM - Business Wire